| Literature DB >> 26248606 |
Lijun Xin1, Tony T Jiang1, Jeremy M Kinder1, James M Ertelt1, Sing Sing Way1.
Abstract
Aging confers increased susceptibility to common pathogens including influenza A virus. Despite shared vulnerability to infection with advancing age in humans and rodents, the relatively long time required for immune senescence to take hold practically restricts the use of naturally aged mice to investigate aging-induced immunological shifts. Here, we show accelerated aging Lmna(Dhe) mice with spontaneous mutation in the nuclear scaffolding protein, lamin A, replicate infection susceptibility, and substantial immune cell shifts that occur with advancing age. Naturally aged (≥ 20 month) and 2- to 3-month-old Lmna(Dhe) mice share near identically increased influenza A susceptibility compared with age-matched Lmna(WT) control mice. Increased mortality and higher viral burden after influenza infection in Lmna(Dhe) mice parallel reduced accumulation of lung alveolar macrophage cells, systemic expansion of immune suppressive Foxp3⁺ regulatory T cells, and skewed immune dominance among viral-specific CD8⁺T cells similar to the immunological phenotype of naturally aged mice. Thus, aging-induced infection susceptibility and immune senescence are replicated in accelerated aging Lmna(Dhe) mice.Entities:
Keywords: accelerated aging; infection susceptibility; models of immune senescence; progeria syndrome
Mesh:
Substances:
Year: 2015 PMID: 26248606 PMCID: PMC4693468 DOI: 10.1111/acel.12385
Source DB: PubMed Journal: Aging Cell ISSN: 1474-9718 Impact factor: 9.304
Figure 1Influenza susceptibility together with skewed alveolar macrophage and regulatory T‐cell accumulation with aging are replicated in accelerated aging Lmna mice. (A) Survival of naturally aged (≥20 month) compared with 2‐ to 3‐month‐old mice (top), and 2‐ to 3‐month‐old Lmna mice compared with age‐matched Lmna control mice (bottom) after intranasal influenza infection. (B) Recoverable influenza viral titers day 8 postinfection for the mice described in panel A. (C) Cell gating scheme, and composite analysis of lung alveolar macrophage cells of ≥20‐month compared with 2‐ to 3‐month‐old mice (top), and 2‐ to 3‐month‐old Lmna mice compared with age‐matched Lmna control mice (bottom). (D) Representative FACS plots and composite analysis of Foxp3+ CD4+ splenocytes in ≥20‐month compared with 2‐ to 3‐month‐old mice (top), and 2‐ to 3‐month‐old Lmna mice compared with littermate Lmna control mice (bottom). These data are representative of at least two independent experiments each with similar results. Bar, mean ± 1 SE. **, P < 0.01; ***, P < 0.001.
Figure 2Skewed immune dominance of influenza virus‐specific CD8+ T cells with aging is replicated in accelerated aging Lmna mice. (A) Representative FACS plots and composite analysis of percent IFN‐γ‐producing mediastinal lymph node CD8+ T cell after stimulation with each influenza‐specific MHC class I peptide compared with no stimulation controls day 8 after influenza A infection (3000 PFUs) in ≥20‐month compared with 2‐ to 3‐month‐old mice (top), or 2‐ to 3‐month‐old Lmna mice compared with littermate Lmna control mice (bottom). (B) Cell gating scheme, and composite analysis of percent IFN‐γ‐producing CD8+ splenocytes after stimulation with PA 224–233 or NP 366–374 peptides for ≥20‐month compared with 2‐ to 3‐month‐old donor mice (top), or 2‐ to 3‐month‐old Lmna mice compared with Lmna donor mice (bottom) day 8 after influenza A infection (3000 PFUs). These data are representative of results from at least two independent experiments with similar results. Bar, mean ± 1 SE. *, P < 0.05.